$2.9 Million NIH Grant for Novel Investigational Therapeutic to Combat Antibiotic-Resistant Gonorrhea
Jennifer Ringler2025-07-15T21:51:38-04:00TAXIS has received a $2.9 million grant to further advance R&D efforts for its dihydrofolate reductase inhibitors (DHFRIs) as a novel approach to combat multi-drug resistant gonorrhea, a rapidly spreading deadly and highly resistant strain of Neisseria gonorrhoeae.